News, research and analysis featuring ACD Bio, an American corporation that is a leader in the field of molecular pathology and a developer of cell and tissue-based analysis tools.

July 11, 2016

Bio-Techne enters Genomics market with $250M acquisition of Advanced Cell Diagnostics

Bio-Techne Corporation have agreed to acquire California-based molecular pathology company Advanced Cell Diagnostics for $250 million in cash plus additional potential milestone payments of up to […]
January 27, 2016

Evolution Analysis: ACD Bio & Leica Biosystems Expand RNAscope Diagnostics Partnership

Advanced Cell Diagnostics and Leica Biosystems have announced a comprehensive partnership to develop and commercialise tissue-based diagnostic tests based on ACD’s RNAscope in situ hybridisation (ISH) […]
June 24, 2015

Advanced Cell Diagnostics raises $22 million USD in latest round of financing

Advanced Cell Diagnostics (ACD) have raised a further $22 million in Series C equity financing, with proceeds to be used to accelerate their entry into the […]
September 30, 2013

ACD Bio Sign Global Distribution Agreement with Life Technologies (Thermo Fisher)

Life Technologies and Advanced Cell Diagnostics Sign Global Distribution Agreement CARLSBAD, CALIFORNIA – Sept. 30, 2013 Life Technologies Corporation (NASDAQ: LIFE) and Advanced Cell Diagnostics, Inc. […]